David Hung Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for David Hung.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David Hung. David Hung is a President and CEO in MEDIVATION, INC. ($MDVN) and an Principal Executive Officer in Axovant Sciences Ltd. ($AXON) and a Director in NovoCure Ltd ($NVCR) and a Director in ESTABLISHMENT LABS HOLDINGS INC. ($ESTA) and a Director in ARYA SCIENCES ACQUISITION CORP. ($ARYA) and a President and CEO in Nuvation Bio Inc. ($PANA).
Address: 501 SECOND STREET SUITE 211 SAN FRANCISCO 94107 CA
Companies in which David Hung is an Insider
ARYA SCIENCES ACQUISITION CORP.
Industry: BLANK CHECKS [6770]
Position of David Hung: Director
Holdings: 0 shares
Latest Transaction: Jul 06 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ESTABLISHMENT LABS HOLDINGS INC.
Industry: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
Position of David Hung: Director
Holdings: 0 shares
Latest Transaction: May 27 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MEDIVATION, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David Hung: President and CEO
Holdings: 0 shares
Latest Transaction: Sep 30 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NovoCure Ltd
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of David Hung: Director
Holdings: 5,900 shares
Current Value: $40,120
Latest Transaction: Jun 12 2020
$NVCR Market Capitalization: $581.43M
$NVCR Previous Close: $6.80
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Nuvation Bio Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David Hung: President and CEO
Holdings: 56,645,012 shares
Latest Transaction: Mar 11 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sio Gene Therapies Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David Hung: Principal Executive Officer
Holdings: 539,375 shares
Current Value: $6,995,694
Latest Transaction: Jan 03 2018
$AXON Market Capitalization: $1.28B
$AXON Previous Close: $12.97
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of David Hung
Sentiment: All, ARYA, ESTA, MDVN, NVCR, NUVB, AXON
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 11 2021 | NUVB | Nuvation Bio Inc. | Hung David | President and CEO | Option Exercise | A | 12.66 | 224,760 | 2,845,462 | 224,760 | |
| Mar 11 2021 | NUVB | Nuvation Bio Inc. | Hung David | President and CEO | Option Exercise | A | 12.66 | 165,465 | 2,094,787 | 165,465 | |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | Hung David | President and CEO | Option Exercise | A | 0.00 | 1,000,000 | 0 | 1,000,000 | |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | Hung David | President and CEO | Grant | A | 10.00 | 2,000,000 | 20,000,000 | 58,645,012 | 56.6 M to 58.6 M (+3.53 %) |
| Feb 12 2021 | PANA | Nuvation Bio Inc. | Hung David | President and CEO | Grant | A | 0.00 | 56,645,012 | 0 | 56,645,012 | 0 to 56.6 M |
| Jul 06 2020 | ARYA | ARYA SCIENCES ACQU ... | Hung David | Director | Option Exercise | D | 0.00 | 30,000 | 0 | 0 | |
| Jun 12 2020 | NVCR | NovoCure Ltd | Hung David | Director | Option Exercise | A | 67.89 | 5,101 | 346,307 | 5,101 |